摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3S,3aR,7aR)-3-hydroxy-2-phenyl-2,3,3a,7a-tetrahydrofuro[3,2-b]pyran-5-one | 114488-17-4

中文名称
——
中文别名
——
英文名称
(2S,3S,3aR,7aR)-3-hydroxy-2-phenyl-2,3,3a,7a-tetrahydrofuro[3,2-b]pyran-5-one
英文别名
(-) Altholactone;(-)-altholactone
(2S,3S,3aR,7aR)-3-hydroxy-2-phenyl-2,3,3a,7a-tetrahydrofuro[3,2-b]pyran-5-one化学式
CAS
114488-17-4
化学式
C13H12O4
mdl
——
分子量
232.236
InChiKey
ZKIRVBNLJKGIEM-IXOXFDKPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    490.4±45.0 °C(predicted)
  • 密度:
    1.336±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A concise and stereoselective synthesis of both enantiomers of altholactone and isoaltholactone
    作者:J.S. Yadav、G. Rajaiah、A.Krishnam Raju
    DOI:10.1016/s0040-4039(03)01413-8
    日期:2003.7
    A concise and flexible stereoselective route to synthesize both enantiomers of the highly functionalized α,β-unsaturated-δ-lactones, altholactone and isoaltholactone, from readily available cinnamyl alcohol is described. This approach derived its asymmetry from Sharpless catalytic asymmetric epoxidation and Sharpless asymmetric dihydroxylation reactions. The resulting diols were produced in high enantiomeric
    描述了一种简明且灵活的立体选择路线,该路线可以从容易获得的肉桂醇合成高度官能化的α,β-不饱和-δ-内酯,对内酯和异对内酯的两种对映异构体。这种方法的不对称性源于Sharpless催化不对称环氧化和Sharpless不对称二羟基化反应。所产生的二醇以高对映体过量产生,并在催化量的樟脑磺酸存在下以立体选择性方式环化。
  • Highly stereoselective synthesis of antitumor agents: both enantiomers of goniothales diol, altholactone, and isoaltholactone
    作者:Jhillu Singh Yadav、Atcha Krishnam Raju、Ponugoti Purushothama Rao、Gurram Rajaiah
    DOI:10.1016/j.tetasy.2005.08.047
    日期:2005.10
    A flexible stereoselective route to synthesize both enantiomers of the highly functionalized substituted tetrahydrofurans and α,β-unsaturated-δ-lactones, goniothales diol, altholactone, and isoaltholactone, from readily available cinnamyl alcohol is described. This approach derived its asymmetry from Sharpless catalytic asymmetric epoxidation and Sharpless asymmetric dihydroxylation reactions. The
    描述了从容易获得的肉桂醇合成高度官能化的取代的四氢呋喃的对映异构体和α,β-不饱和-δ-内酯,菊苣二醇,甲内酯和异甲内酯的对映体的灵活的立体选择性途径。这种方法的不对称性源于Sharpless催化不对称环氧化和Sharpless不对称二羟基化反应。所产生的二醇以高对映体过量产生,并在催化量的樟脑磺酸存在下以立体选择性方式环化。
  • Enantiodivergent synthesis of (+) and (−) altholactone from D-glucose. Preparation and cytotoxic activity of analogs
    作者:J.-P. Gesson、J.-C. Jacquesy、M. Mondon
    DOI:10.1016/s0040-4020(01)80093-4
    日期:1989.1
    Total synthesis of (+)altholactone (goniothalenol), an antitumor pyrone isolated from an unnamed polyalthea species and from goniothalamus giganteus, has been completed in 11 steps from D-glucose using the easily available aldehyde 7. Starting from the same compound or from the related benzoate 24 an enantiodivergent synthesis of (−)1 has also been completed using as the key step an efficient arylation
    (+)内酯(goniothalenol)的全合成,是从D-葡萄糖用11个步骤,使用易于获得的醛7分离的,该抗肿瘤的吡喃酮是从一种未命名的聚阿拉斯木种和从淋菌中分离出来的。从相同的化合物或从相关的苯甲酸酯24开始,通过使用无水HF中的有效芳基化作为关键步骤,完成了(-)1的对映异构体合成。在这些条件下,在C-8处发生差向异构化,从而产生新的8-epi(+)1或其对映异构体。这些吡喃酮中的大多数在体外对L1210白血病表现出有趣的细胞毒性。
  • Enantiospecific syntheses of (+)- and (–)-altholactone (goniothalenol)
    作者:John G. Gillhouley、Tony K. M. Shing
    DOI:10.1039/c39880000976
    日期:——
    (+)-Altholactone (1) and its enantiomer (2) have been synthesised from D-gulonolactone and D-mannose, respectively, with stereocontrolled reduction (Et3SiH/BF3·Et2O) of the lactols (4) and (10) as a key step.
    (+)-内酯(1)及其对映异构体(2)分别由D-古洛内酯和D-甘露糖合成,并通过立体控制还原(Et 3 SiH / BF 3 ·Et 2 O)形成内酯(4)和。 (10)作为关键步骤。
  • Apoptotic activities in closely related styryllactone stereoisomers toward human tumor cell lines: Investigation of synergism of styryllactone-induced apoptosis with TRAIL
    作者:Shuchi Gupta、Lee Poeppelman、Channing. L. Hinman、James Bretz、Richard A. Hudson、L.M. Viranga Tillekeratne
    DOI:10.1016/j.bmc.2009.11.045
    日期:2010.1
    A related series of styryllactones with small functional and stereochemical variations were compiled for a comparative study of their apoptotic activities toward two tumorigenic and one non-tumorigenic control cell line. While a substantial range of intrinsic activity was observed, the relative order of activity of the different compounds toward the cell types varied somewhat as did the relative ratios of apoptosis and necrosis observed in conjunction with the loss of cell viability. While some of the styryllactones showed substantial activity, a small but significant apoptosis-induced synergism was demonstrated with (-)-altholactone and TRAIL (tumor necrosis factor-related apoptosis-inducing ligand). (C) 2009 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

马桑宁内酯 苦毒浆果[木防已属] 苦亭 艾瑞布林中间体 艾瑞布林 甲磺酸艾日布林 木防己苦毒宁 全内酯 二氢苦毒宁 6-甲基-4-氧代-4H-呋喃并[3,2-c]吡喃-3-甲酰氯 6-(4-羟基苯基)-2,3,3-三甲基-2H-呋喃并[5,4-b]吡喃-4-酮 4H-呋喃并[2,3-c]吡喃基莫匹罗星钠 3-甲基2H-呋喃并[2,3-c]吡喃-2-酮 3,5-二甲基2H-呋喃并[2,3-c]吡喃-2-酮 2H-呋喃并[2,3-c]吡喃-2-酮 2-[(1E,3E)-己-1,3-二烯基]-2,6-二甲基-5,6-二氢呋喃并[5,4-b]吡喃-3,4-二酮 (3aS,5S,6R,9E,14R,15R,15aR)-2,3,3a,4,5,6,7,8,11,12,13,14,15,15alpha-十四氢-6,10,14-三甲基-3-亚甲基-2-氧代-5,15-环氧环十四烷并[b]呋喃-6-醇乙酸酯 (3aR,4S,7aR)-4-羟基-3,3a,4,7a-四氢呋喃并[5,4-b]吡喃-2-酮 5-hydroxymethyl-3-methyl-2H-furo[2,3-c]pyran-2-one 5-fluoromethyl-2H-furo[2,3-c]pyran-2-one 5-chloromethyl-2H-furo[2,3-c]pyran-2-one 10,11-Anhydro-5-deoxy-1,2-O-isopropylidene-9-O-(methoxymethyl)-β-L-xylo-L-ido-7-undeculofuranose-(1,4)-pyranose-(7,3) 3,7-dimethyl-2H-furo[2,3-c]pyran-2-one 4R-(3αβ,3aβ,4β,5α,6β,7aβ)hexahydro-2,2-dimethyl-4,5-bis(phenylmethoxy)-6-[(phenylmethoxy)methyl]4H-furo[2,3-b]pyran-3-ol 10,10-dimethyl-5-(methylsulfanyl)-10,11-dihydro-8H-pyrano[4',3':4,5]furo[3,2-e]tetrazolo[1,5-c]pyrimidine (R)-3-((2R,3R,5aR,7R,9aS)-3-hydroxyhexahydro-2H-2,5a-methanopyrano[3,2-e][1,4]dioxepin-7-yl)-2-methylpropanenitrile 13-methyl-8,10,12-trioxapentacyclo[5.5.2.02,6.O3,11.05,9]-13-tetradecene 2,3,4,4a,7,8-Hexahydro-6H-2-(acetoxymethyl)-3,4-diacetoxy-1,9-dioxacyclohexainden-5-one 2,3,4,4a,7,8-Hexahydro-6H-2-methoxy-1,9-dioxacyclohexainden-5-one (-)-3a-methyl-3a,4-dihydro-1H,3H-furo[3,4-c]pyran-6,6,7-tricarboxylic acid 6,6-diethyl ester 7-methyl ester (+)-8-epi-altholactone 4-(perfluorophenyl)-3-phenylhexahydro-1H-furo[3,4-c]pyran [(2R,11S,12R,14R,15R,17R,19S)-19-tert-butyldiphenylsiloxymethyl-15-methyl-13,18-dioxadispiro(2H-3,6-dihydropyran-6,5'-oxolane-2',3''-bicyclo[4.3.0]nonane)-2-yl]phenylmethoxymethane (3aS,5S,9bS)-5-methyl-3,3a-dihydro-5H-furo[3,2-c]isochromene-2,6,9-(9bH)-trione (3aR,5R,7aR)-5-(2-hydroxypropan-2-yl)-7a-methylhexahydro-2H-furo[3,2-b]pyran-2-one 2,2,3b-trimethyl-7-vinyl-3a,5,7a,8a-tetrahydro-3bH-1,3,4,8-tetracyclopenta[a]indene ethyl 4-oxo-3-phenyl-3,3a,4,6-tetrahydro-1H-furo[3,4-c]pyran-3a-carboxylate methyl (2R,2aR,4aS,7aS,7bS)-2-methoxy-6-methyl-4-oxo-5-pentyl-2a,4,4a,7b-tetrahydro-2H-1,3,7-trioxacyclopenta[cd]indene-7a-carboxylate 4-nonyl-3-phenylhexahydro-1H-furo[3,4-c]pyran 3'-(4-methoxyphenyl)-7a'-methyl-4'H,6'H-spiro[cyclohexane-1,5'-furo[2,3-b]pyran]-2'(7a'H)-one 3',7a'-dimethyl-4'H,6'H-spiro[cyclohexane-1,5'-furo[2,3-b]pyran]-2'(7a'H)-one 2-(methylsulfanyl)-5,6-dihydro-4H-furo[2,3-b]pyran 1,1-(3-dimethylamino-3-phenylpentamethylen)-3,4-dihydro-1H-2,9-dioxafluoren 7-cyclopropyl-4,5,7,7a-tetrahydro-furo[2,3-c]pyran-2-one 7-cyclopropyl-3-phenyl-4,5,7,7a-tetrahydro-furo[2,3-c]pyran-2-one 7-cyclopropyl-3-phenyl-4,5,7,7a-tetrahydro-furo[2,3-c]pyran-2-one (4'R)-6-O-(4-cyanophenyl)-1,2,3,4-tetradeoxy-4'-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluorononyl)-2',3',4',5'-tetrahydro-α-D-erythro-hexopyranoso[1,2-b]furan 2,2,3,6-tetramethyl-2,3-dihydro-4H-furo[2,3-b]pyran-4-one (1aR,4aS,5R)-7-carboethoxy-5-methylethyl-tetrahydrofurano[2,3-b]3,4-dihydro-2H-pyran (3aS,4S,7aR)-ethyl 4-methyl-3,3a,4,7a-tetrahydro-2H-furo[2,3-b]pyran-6-carboxylate